本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

65.83
+0.48000.73%
成交量:87.35万
成交额:5,753.83万
市值:128.90亿
市盈率:-18.45
高:66.42
开:65.35
低:65.21
收:65.35
52周最高:93.42
52周最低:52.75
股本:1.96亿
流通股本:1.67亿
量比:0.48
换手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-26.00%
市净率:-5.12
市盈率(LYR):-17.39

数据加载中...

2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/03

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/23

重要事件披露

Form 8-K - Current report
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities